GSK Gsk Plc

TIDMGSK

RNS Number : 5246D

GlaxoSmithKline PLC

19 February 2020

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.    Details of PDMR/person closely associated with them ('PCA') 
====  =========================================================================================== 
 a)    Name                                   Ms D Waterhouse 
====  ======================================  =================================================== 
 b)    Position/status                        CEO of ViiV Healthcare 
====  ======================================  =================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  =================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  =================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  =================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  =================================================== 
 b)    Nature of the                          Following the vesting on 16 February 2020 
        transaction                            of 25% of an award made on 16 February 
                                               2015 under the GlaxoSmithKline Deferred 
                                               Investment Award programme, Ms Waterhouse 
                                               will receive a cash payment of GBP240,634.43 
                                               less applicable tax withholding in respect 
                                               of 14,421.337 notional Ordinary Shares. 
====  ======================================  =================================================== 
 c)    Price(s) and                            Price(s)                Volume(s) 
        volume(s) 
====  ======================================   ======================  ======================== 
   GBP16.686                                                           14,421.337 
   ==================================================================  ======================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ===============================================================  =============================== 
 e)    Date of the transaction                2020-02-16 
====  ======================================  =================================================== 
 f)    Place of the                           N/A 
        transaction 
====  ======================================  =================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHDKLFFBLLLBBL

(END) Dow Jones Newswires

February 19, 2020 12:25 ET (17:25 GMT)

Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024

Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024